###begin article-title 0
The Imbalance in Serum Concentration of Th-1- and Th-2-Derived Chemokines as One of the Factors Involved in Pathogenesis of Atopic Dermatitis
###end article-title 0
###begin p 1
Recommended by Vera L. Petricevich
###end p 1
###begin p 2
###xml 264 272 <span type="species:ncbi:9606">patients</span>
###xml 295 303 <span type="species:ncbi:9606">patients</span>
###xml 396 404 <span type="species:ncbi:9606">patients</span>
Atopic dermatitis (AD) is an inflammatory skin disease in which pathogenesis chemokines are partially involved. The aim of the paper was to assess the serum level of CXCL-9, CXCL-10, CXCL-11, CXCL-12, CCL-17, CCL-20, CCL-21, CCL-22, CCL-27, and IL-18 chosen in AD patients by ELISA assay. Forty patients (mean age 11.4 years old) with AD and 50 healthy controls were enrolled into the study. The patients and controls were divided into two age categories: under 10 years old (Group 1 and Control 1) and over 10 years old (Group 2 and Control 2). Significantly lower serum concentration of CXCL-9, CXCL-10, CCL-17, and IL-18 and higher concentration of CXCL-12 and CCL-27 were found in Group 1 when compared to Control 1. In Group 2 serum concentration of CXCL-12, CCL-17, CCL-22 was higher than in Control 2. The obtained results indicate the imbalance in chemokine serum levels in AD what suggests their role in the disease pathogenesis.
###end p 2
###begin title 3
1. Introduction
###end title 3
###begin p 4
###xml 95 96 95 96 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 250 251 250 251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 548 549 548 549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 551 552 551 552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 178 186 <span type="species:ncbi:9606">patients</span>
Atopic dermatitis (AD) is a chronic and recurrent disease which concerns 10-20% of population [1]. The onset of AD is usually before 2 years old, and in approximately 60% of the patients skin lesions of different intensity remain for the whole life [2]. AD is characterized by typical morphology and distribution of skin lesions, severe pruritus, and familial atopic history. Clinical phenotype of the disease depends on multiple interactions between genetic and immunological disturbances, epidermal barrier impairment, and environmental factors [3, 4]. 
###end p 4
###begin p 5
###xml 125 126 125 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 283 284 283 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 286 287 286 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 514 515 514 515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 171 179 <span type="species:ncbi:9606">patients</span>
Histopathologically skin lesions present mainly with a dermal infiltrate of mainly CLA+ memory T cells and Langerhans cells [5]. Leukocyte trafficking into the skin in AD patients is probably mainly regulated by adhesion molecules and chemoattractive proteins, so-called chemokines [6, 7]. Chemokines are small secreted proteins involved in migration and activation of lymphocytes T. Recently published papers indicate their role in pathogenesis of multiple inflammatory skin diseases including atopic dermatitis [8]. 
###end p 5
###begin p 6
###xml 427 428 427 428 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 430 432 430 432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 634 636 634 636 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 638 640 638 640 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 331 339 <span type="species:ncbi:9606">patients</span>
###xml 556 564 <span type="species:ncbi:9606">patients</span>
In active skin lesions in the course of AD infiltrates of Th-2 lymphocytes releasing IL-4 and/or IL-13 are found. These cells express CCR4, CCR8, and CRTH2 receptors on their surface. Lymphocytes Th-2 migration is selectively induced by such chemokines as CCL17 and CCL22, which are highly overexpressed on the keratinocytes in AD patients epidermis. These phenomena lead in a consequence to development of local inflammation [9, 10]. In the studies analyzing serum concentration of these chemokines, increased levels of CCL-17 and CCL-22 were found in AD patients, and their concentrations strongly correlated with disease activity [11, 12]. 
###end p 6
###begin p 7
###xml 16 18 16 18 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 521 523 521 523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 106 114 <span type="species:ncbi:9606">patients</span>
###xml 315 323 <span type="species:ncbi:9606">patients</span>
Shimada et al. [13] found increased levels of Th-2 (CCL-17 and CCL-22) and Th-1 (CXCL-9) chemokines in AD patients. They also found a positive correlation between Th-2 chemokines serum level and total IgE concentration, moreover Th-2 chemokines correlated with Th-1 ones. In another study performed in infantile AD patients (mean age 4.5 months) also increased levels of CCL-17, CCL-20, CCL-27 were observed which strongly correlated with disease activity, however the most prominent correlation was observed for CCL-27 [14]. 
###end p 7
###begin p 8
###xml 262 264 262 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 266 268 266 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 199 207 <span type="species:ncbi:9606">patients</span>
Interleukin (IL)-18 is involved in pathogenesis of type-2 helper cells-mediated diseases including atopic dermatitis. According to literature, its serum concentration is significantly elevated in AD patients and correlates with clinical severity of the disease [15, 16].
###end p 8
###begin p 9
###xml 230 238 <span type="species:ncbi:9606">patients</span>
###xml 391 398 <span type="species:ncbi:9606">patient</span>
Most literature data point out an important role of chemokine network imbalance in development of atopic dermatitis, however there are scarce data on the complex analysis of serum levels of Th-1- and Th-2-derived chemokines in AD patients. Thus, the aim of the paper was to assess the serum level of CXCL-9, CXCL-10, CXCL-11, CXCL-12, CCL-17, CCL-20, CCL-21, CCL-22, CCL-27, IL-18 in two AD patient groups, below and over 10 years old. Additionally we analyzed serum levels of the chosen chemokines in two groups of healthy volunteers, aged-matched, to note any age-dependent variations in healthy population.
###end p 9
###begin title 10
2. Material and Methods
###end title 10
###begin title 11
###xml 5 13 <span type="species:ncbi:9606">Patients</span>
2.1. Patients
###end title 11
###begin p 12
###xml 206 208 206 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 300 301 300 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 340 341 340 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 446 447 446 447 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 486 487 486 487 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 672 679 672 679 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tab1">Table 1</xref>
###xml 6 14 <span type="species:ncbi:9606">patients</span>
###xml 224 232 <span type="species:ncbi:9606">patients</span>
###xml 646 654 <span type="species:ncbi:9606">patients</span>
Forty patients (mean age 11.4 years old; 23 F, 15 M) with AD and 50 healthy controls, age and sex matched were enrolled into the study. AD was diagnosed according to criteria proposed by Hanifin and Rajka [17]. The enrolled patients were divided into two age categories: under 10 years old (Group 1; n = 23) and over 10 years old (Group 2; n = 17). According to this criterion, the control group was divided as well (Control 1 under 10 years old n = 30; and Control 2 over 10 years old n = 20). We used criterion of 10 years old as a cut-off point because this age is believed to initiate adolescence life period. Clinical characteristics of the patients are presented in Table 1.
###end p 12
###begin title 13
2.2. Methods
###end title 13
###begin p 14
###xml 377 379 377 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 5 12 <span type="species:ncbi:9606">patient</span>
###xml 386 394 <span type="species:ncbi:9606">patients</span>
Each patient or his/her parents gave written informed consent before entering the study, and all the experiments were approved by the Local Ethics Committee. The investigations were carried out in accordance with Declaration of Helsinki. Before entering the study the subjects underwent thorough physical examination, and scoring atopic dermatitis (SCORAD) index was assessed [18]. The patients enrolled to the study had moderate AD (mean SCORAD index 23 range 16-39). Serum samples were analyzed for CXCL-9, CXCL-10, CXCL-11, CXCL-12, CCL-17, CCL-20, CCL-21, CCL-22, CCL-27, IL-18 concentration with ELISA assay (R&D system, Mineapolis, Minn, USA) according to manufacturer's instructions. The concentrations were calculated from the standard curve generated by curve-fitting programme.
###end p 14
###begin title 15
3. Statistical Analysis
###end title 15
###begin p 16
###xml 143 144 143 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Data were analyzed using the Mann-Whitney U test, and correlations coefficients were determined by using the Spearman rank correlation test. A P-value of <.05 was considered as statistically significant.
###end p 16
###begin title 17
4. Results
###end title 17
###begin p 18
###xml 150 157 150 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tab2">Table 2</xref>
Median concentrations of all the analyzed proteins: CXCL-9, CXCL-10, CXCL-11, CXCL-12, CCL-17, CCL-20, CCL-21, CCL-22, CCL-27, IL-18 are presented in Table 2.
###end p 18
###begin title 19
###xml 120 128 <span type="species:ncbi:9606">Patients</span>
4.1. The Median Concentration of CXCL-9, CXCL-10, CXCL-11, CXCL-12, CCL-17, CCL-20, CCL-21, CCL-22, CCL-27, IL-18 in AD Patients below 10 Years Old (Group 1)
###end title 19
###begin p 20
###xml 186 187 186 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 226 227 226 227 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 267 268 267 268 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 306 307 306 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 482 483 482 483 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 524 525 524 525 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 643 644 643 644 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 102 110 <span type="species:ncbi:9606">patients</span>
The median serum CXCL-9, CXCL-10, CCL-17, and IL-18 level was statistically significantly lower in AD patients from Group 1 when compared to the Control 1 (56.7 pg/mL versus 87.3 pg/mL; P = .003; 84.8 pg/mL versus 98.0 pg/mL; P = .04; 405.2 pg/mL versus 620.1 pg/mL, P = .04; 64.8 pg/mL versus 94.7 pg/mL, P = .0001; resp.). In Group 1 the median serum concentration of CXCL-12 and CCL-27 was significantly higher than that in the Control 1 group (2444.9 pg/mL versus 2135.8 pg/mL, P = .004; 463.5 pg/mL versus 406.6 pg/mL, P = .03; resp.). For other chemokines median serum values did not differ statistically when compared to the Control 1 (P > .05 for all comparisons).
###end p 20
###begin title 21
###xml 120 128 <span type="species:ncbi:9606">Patients</span>
4.2. The Median Concentration of CXCL-9, CXCL-10, CXCL-11, CXCL-12, CCL-17, CCL-20, CCL-21, CCL-22, CCL-27, IL-18 in AD Patients over 10 Years Old (Group 2)
###end title 21
###begin p 22
###xml 175 176 175 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 216 217 216 217 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 258 259 258 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 378 379 378 379 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 84 92 <span type="species:ncbi:9606">patients</span>
The median serum CXCL-12, CCL-17, and CCL-22 levels were significantly higher in AD patients from Group 2 than in the age-matched Control 2 (2553.5 pg/mL versus 2361.1 pg/mL, P = .01; 357.6 pg/mL versus 178.3 pg/mL, P = .04; 1152.5 pg/mL versus 606.1 pg/mL, P = .001; resp.). For other chemokines median serum values did not differ statistically when compared to the Control 2 (P > .05 for all comparisons).
###end p 22
###begin title 23
4.3. Differences in the Median Concentration of CXCL-9, CXCL-10, CXCL-11, CXCL-12, CCL-17, CCL-20, CCL-21, CCL-22, CCL-27, IL-18 between Groups 1 and 2
###end title 23
###begin p 24
###xml 278 279 278 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 186 194 <span type="species:ncbi:9606">children</span>
Comparing serum median levels of analyzed chemokines between two AD groups (Group 1 versus Group 2) the only significant difference was found for CCL-20 which median value was higher in children below 10 years old than in older population (Group 2) (7.8 pg/mL versus 7.4 pg/mL; P = .03).
###end p 24
###begin title 25
4.4. Differences in the Median Concentration of CXCL-9, CXCL-10, CXCL-11, CXCL-12, CCL-17, CCL-20, CCL-21, CCL-22, CCL-27, IL-18 between Controls 1 and 2
###end title 25
###begin p 26
###xml 233 234 233 234 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 275 276 275 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 317 318 317 318 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 355 356 355 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 398 399 398 399 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 440 441 440 441 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 562 563 562 563 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Comparing CXCL-9, CXCL-11, CCL-17, CCL-20, CCL-22, and IL-18 serum median concentration between Controls 1 and 2 we found significantly higher values in younger population (Control 1) than in Control 2 (87.3 pg/mL versus 17.9 pg/mL, P = .00004; 66.9 pg/mL versus 43.3 pg/mL, P = .049; 620.1 pg/mL versus 178.3 pg/mL, P = .001; 8.3 pg/mL versus 6.9 pg/mL, P = .008; 1410.2 pg/mL versus 606.1 pg/mL, P = .00003; 94.7 pg/mL versus 97.2 pg/mL, P = .049; resp.). For other chemokines median serum values did not differ statistically when compared two control groups (P > .05 for all comparisons).
###end p 26
###begin title 27
4.5. Correlations between Median Serum Levels of CXCL-9, CXCL-10, CXCL-11, CXCL-12, CCL-17, CCL-20, CCL-21, CCL-22, CCL-27, IL-18 in Analyzed Groups
###end title 27
###begin p 28
###xml 79 80 79 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 89 90 89 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 119 120 119 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 129 130 129 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 162 163 162 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 171 172 171 172 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 200 208 <span type="species:ncbi:9606">patients</span>
Positive correlation between median serum concentration of CXCL-11 and CXCL-9 (r = 0.44, P = .03), CXCL-9 and CXCL-10 (r = 0.42, P = .04), and CXCL-10 and IL-18 (r = 0.8, P = .000001) was found in AD patients below 10 years old (Group 1).
###end p 28
###begin p 29
###xml 176 177 176 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 186 187 186 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 220 221 220 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 229 230 229 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 262 263 262 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 272 273 272 273 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 303 304 303 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 313 314 313 314 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 342 343 342 343 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 352 353 352 353 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 385 386 385 386 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 395 396 395 396 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 429 430 429 430 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 438 439 438 439 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 570 571 570 571 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 580 581 580 581 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 15 23 <span type="species:ncbi:9606">patients</span>
###xml 555 563 <span type="species:ncbi:9606">patients</span>
In Group 2 (AD patients over 10 years old) we found positive correlations of the median serum levels of the analyzed proteins for the following parameters: CXCL-11 and CXCL-9 (r = 0.85, P = .00001), CXCL-11 and CXCL-10 (r = 0.8, P = .00006), CXCL-11 and CCL-20 (r = 0.96, P < .001), CXCL-9 and CXCL-10 (r = 0.59, P = .01), CXCL-9 and CCL-20 (r = 0.84, P = .00002), CXCL-10 and CCL-20 (r = 0.79, P = .0002), and CCL-17 and IL-18 (r = 0.5, P = .03). Moreover in this group we observed a positive correlation between serum median concentration of CCL-22 and patients' age (r = 0.52, P = .003).
###end p 29
###begin p 30
###xml 114 115 114 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 123 124 123 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 153 154 153 154 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 163 164 163 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 193 194 193 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 203 204 203 204 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 234 235 234 235 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 244 245 244 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 274 275 274 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 284 285 284 285 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 370 371 370 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 381 382 381 382 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 521 522 521 522 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 531 532 531 532 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 541 542 541 542 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 552 553 552 553 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 458 466 <span type="species:ncbi:9606">patients</span>
In Control 1 we found positive correlations between serum levels of the following chemokines: CXCL-11 and CCL-21 (r = 0.4, P = .03), CXCL-11 and CCL-22 (r = 0.37, P = .04), CXCL-11 and CCL-17 (r = 0.36, P = .048), CXCL-9 and CXCL-10 (r = 0.47, P = .008), CCL-17 and CCL-22 (r = 0.68, P = .00003). Contrary, negative correlation between serum level of CCL-21 and CXCL-9 (r = -0.36, P = .04) was noted. Analysing correlation between serum chemokine levels and patients' age we found a negative link for CCL-21 and CCCL-22 (r = -0.5, P = .004; r = -0.36, P = .048; resp.).
###end p 30
###begin p 31
###xml 107 108 107 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 117 118 117 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 127 128 127 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 136 137 136 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
In the Control 2 positive correlations were found only between CXCL-10 and CCL-21, and CXCL-17 and CCL-20 (r = 0.84, P = .002; r = 0.9, P = .0003; resp.).
###end p 31
###begin p 32
###xml 346 347 346 347 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 357 358 357 358 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 366 367 366 367 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 377 378 377 378 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 390 391 390 391 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 400 401 400 401 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 140 148 <span type="species:ncbi:9606">patients</span>
Taking the whole AD group (Group 1 and 2) into statistical analysis we found no correlation between serum levels of analyzed parameters and patients' age, while doing the same analysis for whole control group (Control 1 + Control 2) we found negative correlations between age of the subjects and the following proteins: CCL-17, CCL-22 and IL-18 (r = -0.38, P = .01; r = -0.67, P = .000002; r = -0.3, P = .045; resp.).
###end p 32
###begin title 33
4.6. Correlations between Median Serum Levels of CXCL-9, CXCL-10, CXCL-11, CXCL-12, CCL-17, CCL-20, CCL-21, CCL-22, CCL-27, IL-18 and IgE Concentration and Eosinophilia in Analyzed Groups
###end title 33
###begin p 34
###xml 99 100 99 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 109 110 109 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 162 163 162 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 172 173 172 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 191 192 191 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 202 203 202 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 223 224 223 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 233 234 233 234 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 364 365 364 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 374 375 374 375 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
In Group 1 a positive correlation between mean total IgE serum concentration and CCL-20 was found (r = 0.52, P = .009), while in Group 2 it was found for CCL-17 (r = 0.68, P = .002), CCL-27 (r = 0.049, P = .046) and IL-18 (r = 0.58, P = .01). Analysing all the subjects from AD group (Group 1 and 2) IgE serum concentration correlated positively only with CCL-17 (r = 0.49, P = .01).
###end p 34
###begin p 35
###xml 100 101 100 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 110 111 110 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 131 132 131 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 141 142 141 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 225 226 225 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 235 236 235 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 356 357 356 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 366 367 366 367 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 6 14 <span type="species:ncbi:9606">patients</span>
In AD patients below 10 years old (Group 1) a positive correlation between eosinophilia and CCL-20 (r = 0.53, P = .009) and IL-18 (r = 0.45, P = .03) was noted while in Group 2 eosinophilia correlated positively with CCL-27 (r = 0.52, P = .03). Analyzing all the subjects from AD group (Groups 1 and 2) eosinophilia correlated positively only with CCL-22 (r = 0.36, P = .02).
###end p 35
###begin title 36
5. Discussion
###end title 36
###begin p 37
###xml 276 278 276 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 376 378 376 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 380 382 380 382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
Chemokines are small proteins which contribute to leukocytes trafficking into the skin. CXCL-9, CXCL-10, and CXCL-11 recruit lymphocytes mainly to Th-1 type inflammatory sites while chemokines such as CCL-11, CCL-17, CCL-22 lead to Th-2 dominated pattern of cell recruitment [19]. CCL-27 selectively attracts CLA + memory T cells via CCR-10 receptor expressed on these cells [20, 21].
###end p 37
###begin p 38
###xml 152 154 152 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 156 158 156 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 173 175 173 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 59 67 <span type="species:ncbi:9606">patients</span>
###xml 208 216 <span type="species:ncbi:9606">children</span>
###xml 548 556 <span type="species:ncbi:9606">patients</span>
###xml 757 765 <span type="species:ncbi:9606">patients</span>
Recent data indicate increased serum level of CCL-27 in AD patients, correlating with disease activity, what suggests its role in inflammatory process [22, 23]. Hon et al. [23] assessed CCL-27 serum level in children aged 1-11 years with mean SCORAD [29.7] and found its higher serum concentration, what is in line with our results, however contrary to the authors we found no correlation between CCL-27 and CCL-17 and CCL-22 concentrations. Also level of CCL-17 in Group 1, although statistically different than that in Control 1, was lower in AD patients than in healthy ones. Such discrepancy between our results and published ones in other papers, indicates that it is still unclear either increased or decreased CCL-17 level is a characteristic for AD patients, however its distinct level when compared to the control groups testifies its role in AD pathogenesis. In our study similar observations concern CXCL-9, CXCL-10, and IL-18. 
###end p 38
###begin p 39
###xml 470 472 470 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 639 641 639 641 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 27 35 <span type="species:ncbi:9606">patients</span>
###xml 264 272 <span type="species:ncbi:9606">patients</span>
Interestingly, in Group 2 (patients over 10 years old) we found elevated serum levels of CCL-17, CCL-22, and CXCL-12 what also proves their role in AD pathogenesis. Other authors also showed significantly higher concentrations of CCL-17, CCL-22, and eotaxin in AD patients than in healthy control. They found positive correlations between serum level of CCL-17 and CCL-22 and total IgE concentration and as well these chemokines correlated positively with SCORAD index [24]. In our study CCL-17, CCL-27 and IL-18 serum levels correlated positively with total IgE in Group 2, and eosinophilia correlated positively with CCL-27. Hon et al. [25] revealed correlation between IgE and CCL-17 and eosinophiles count but not with CCL-27 what is only partially consistent with our results.
###end p 39
###begin p 40
###xml 296 301 296 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 309 314 305 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 470 472 462 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 474 476 466 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 31 39 <span type="species:ncbi:9606">patients</span>
###xml 602 610 <span type="species:ncbi:9606">patients</span>
In skin biopsies taken from AD patients CCL-20 expression is observed in basal layer of epidermis. This protein is a strong chemoattractant for immature dendritic cells and memory T cells via interactions with CCR6. CCL20 may be induced on keratinocytes under proinflammatory cytokines such: IL-1alpha or TNF-alpha. In healthy epidermis CCL20 is constitutively expressed in epidermal basal layer, however its expression is significantly lower than in inflammatory skin [26, 27]. These data prove CCL-20 role in AD pathogenesis. Although we found no differences between CCL-20 serum concentration in AD patients and controls, its higher concentration was observed in Group 1 than in Group 2. Moreover, in younger population (Group 1) IgE and eosinophilia correlated with CCL-20. To our knowledge, there are no data in literature on the subjects, however observed association and data mentioned above provide its role in AD pathogenesis in younger population and its level normalization in line with the age. 
###end p 40
###begin p 41
###xml 473 475 473 475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 495 497 495 497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 65 73 <span type="species:ncbi:9606">patients</span>
###xml 854 862 <span type="species:ncbi:9606">patients</span>
To our knowledge, there are no data on CCL-21 serum levels in AD patients. We examined this chemokine as it is strongly chemoattractive to lymphocytes T, enhances expression of LFA-1 on these cells, and mediates cell-to-cell adhesion. Besides, CCL-21 and CCR7 receptor influence naive T cell migration to lymph nodes where antigen is presented. In healthy skin immunostaining for CCL21 is negative, however it is expressed on dermal endothelial cells in atopic dermatitis [28]. Weninger et al. [29] showed that CCL21 expression on blood vessels positively correlated with the presence of CD45RA+ T cells in the inflammatory infiltrate. Although CCL21 expression was found in inflammatory T cell-mediated diseases, its exact role in their pathogenesis is not elucidated. Our study in which we found no differences in CCL-21 serum concentration between AD patients and controls does not prove the role of the chemokine in AD pathogenesis. 
###end p 41
###begin p 42
To assess chemokines serum levels depending on age in healthy population, we attempted to check differences between Controls 1 and 2. Our analysis revealed a distinct pattern in healthy population than that in AD groups. In younger healthy population we found increased levels of CXCL-9, CXCL-11, CCL-17, CCL-20, CCL-22, and IL-18 while comparing Groups 1 and 2 the only significance concerned CCL-20. 
###end p 42
###begin p 43
###xml 43 45 43 45 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 98 106 <span type="species:ncbi:9606">patients</span>
###xml 108 116 <span type="species:ncbi:9606">children</span>
###xml 199 207 <span type="species:ncbi:9606">children</span>
###xml 298 306 <span type="species:ncbi:9606">patients</span>
###xml 758 766 <span type="species:ncbi:9606">patients</span>
###xml 955 963 <span type="species:ncbi:9606">patients</span>
 In the study published by Furusyo et al. [30] no differences in serum level of CCL-17 between AD patients (children 0-5 years old) and age-matched healthy control were revealed. Moreover in healthy children they observed that serum CCL-17 concentration decreased with age while serum CCL-17 in AD patients did not differ in relation to age. The authors revealed strong dependence between CCL-17 serum concentration and AD course during childhood. These data are partially consistent with ours, as we also observed a decrease in CCL-17 with age in healthy population and no such age-dependence in AD group. To our knowledge there are no more data analyzing chemokines in this aspect. Lack of these naturally occurring changes in chemokine serum levels in AD patients provides their role in the disease pathogenesis. This hypothesis may be partially proven by our observation on the lack of correlation between age and chosen chemokines serum levels in AD patients and the presence of multiple negative correlations between CCL-17, CCL-22, IL-18, and age in the whole control group. 
###end p 43
###begin p 44
###xml 43 51 <span type="species:ncbi:9606">children</span>
###xml 482 490 <span type="species:ncbi:9606">patients</span>
###xml 1025 1033 <span type="species:ncbi:9606">patients</span>
 Concluding, we may assume that in younger children with AD a decreased serum level of Th-1-derived chemokines is one of the factors involved in the disease development. The imbalance between Th-1 and Th-2 is probably involved in AD pathogenesis as well, what in our paper is especially emphasized by differences in chemokine concentration between two AD groups and two age-matched controls. Our study, similar to others, revealed significant changes between chemokine levels in AD patients and controls, however not always consistent with other authors what may result from two main reasons. The first one is a new aspect of AD pathogenesis, mostly focused now on the impairment of epidermal barrier and innate immune defense as the primary causative factors involved in AD; only these disturbances lead secondary to induction of adaptive immune response, inflammation development involving chemokines disturbances. The second reason may be the lack of objective and standardized method for AD clinical evaluation, thus the patients enrolled to the studies in different centers, although with the same SCORAD index, may have a little different clinical picture. 
###end p 44
###begin p 45
###xml 188 196 <span type="species:ncbi:9606">patients</span>
 Based on literature and our results we conclude that chemokine imbalance is involved in AD pathogenesis, however discrepancies obtained in many studies and relatively small number of the patients included in our study do not allow to draw equivocal conclusions. In our opinion further studies correlating chemokine serum levels, their expression in the skin, and AD clinical picture are required and probably will give new light on the disease pathogenesis.
###end p 45
###begin title 46
Acknowledgments
###end title 46
###begin p 47
The study was funded by Grants from Polish Scientific Committee no. NN402434933 and from the Medical University of Lodz no. 503-1152-1. The authors declare no conflict of interest.
###end p 47
###begin article-title 48
Disease management of atopic dermatitis: an updated practice parameter
###end article-title 48
###begin article-title 49
Current management of atopic dermatitis and interruption of the atopic march
###end article-title 49
###begin article-title 50
Allergic and nonallergic forms of atopic diseases
###end article-title 50
###begin article-title 51
###xml 108 116 <span type="species:ncbi:9606">patients</span>
Differential in vivo cytokine mRNA expression in lesional skin of intrinsic vs. extrinsic atopic dermatitis patients using semiquantitative RT-PCR
###end article-title 51
###begin article-title 52
Atopic dermatitis
###end article-title 52
###begin article-title 53
Lymphocyte homing and hemostasis
###end article-title 53
###begin article-title 54
Chemokines in tissue-specific and micro environment-specific lymphocyte homing
###end article-title 54
###begin article-title 55
Recent advances in chemokines and chemokine receptors
###end article-title 55
###begin article-title 56
###xml 63 68 <span type="species:ncbi:9606">human</span>
Expression of the chemokine receptors CCR4, CCR5, and CXCR3 by human tissue-infiltrating lymphocytes
###end article-title 56
###begin article-title 57
CC chemokine receptor (CCR)4 and the CCR10 ligand cutaneoius T cell-attracting chemokine (CTACK) in lymphocytes trafficking to inflamed skin
###end article-title 57
###begin article-title 58
Thymus and activation-regulated chemokine in atopic dermatitis: serum thymus and activation-regulated chemokine level is closely related with disease activity
###end article-title 58
###begin article-title 59
Serum macrophage-derived chemokine (MDC) levels are closely related with the disease activity of atopic dermatitis
###end article-title 59
###begin article-title 60
###xml 96 104 <span type="species:ncbi:9606">patients</span>
Both Th-2 and Th1 chemokines (TARC/CCL-17, MDC/CCL-22 and MIG/CXCL-9) are elevated in sera from patients with atopic dermatitis
###end article-title 60
###begin article-title 61
Serum levels of Th2 chemokines, CCL17, CCL22, and CCL27, were the important markers of severity in infantile atopic dermatitis
###end article-title 61
###begin article-title 62
###xml 67 75 <span type="species:ncbi:9606">patients</span>
Clinical significance of serum interleukin-18 concentration in the patients with atopic dermatitis
###end article-title 62
###begin article-title 63
###xml 100 108 <span type="species:ncbi:9606">children</span>
The relationship between serum levels of total IgE, IL-18, IL-12, IFN-gamma and disease severity in children with atopic dermatitis
###end article-title 63
###begin article-title 64
Diagnostic features of atopic dermatitis
###end article-title 64
###begin article-title 65
Practical issues on interpretation of scoring atopic dermatitis: the SCORAD index, objective SCORAD and the three-item severity score
###end article-title 65
###begin article-title 66
The molecular basis of lymphocyte recruitment to the skin: clues for pathogenesis and selective therapies of inflammatory disorders
###end article-title 66
###begin article-title 67
CCL27-CCR10 interactions regulate T cell-mediated skin inflammation
###end article-title 67
###begin article-title 68
###xml 102 107 <span type="species:ncbi:10090">mouse</span>
CCL27 is a critical factor for the development of atopic dermatitis in the keratin-14 IL-4 transgenic mouse model
###end article-title 68
###begin article-title 69
Serum thymus and activation-regulated chemokine (TARC) and cutaneous T cell-attracting chemokine (CTACK) levels in allergic diseases: TARC and CTACK are disease-specific markers for atopic dermatitis
###end article-title 69
###begin article-title 70
###xml 125 133 <span type="species:ncbi:9606">children</span>
Serum levels of cutaneous T-cell attracting chemokine (CTACK) as a laboratory marker of the severity of atopic dermatitis in children
###end article-title 70
###begin article-title 71
Serum thymus and activation-regulated chemokine, macrophage-derived chemokine and eotaxin as markers of severity of atopic dermatitis
###end article-title 71
###begin article-title 72
###xml 79 87 <span type="species:ncbi:9606">children</span>
Are age-specific high serum IgE levels associated with worse symptomatology in children with atopic dermatitis?
###end article-title 72
###begin article-title 73
###xml 105 109 <span type="species:ncbi:10090">mice</span>
CXCL12 and CCL20 play a significant role in mucosal T-lymphocyte adherence to intestinal microvessels in mice
###end article-title 73
###begin article-title 74
Distinct patterns of gene expression in the skin lesions of atopic dermatitis and psoriasis: a gene microarray analysis
###end article-title 74
###begin article-title 75
Endothelial induction of the T-cell chemokine CCL21 in T-cell autoimmune diseases
###end article-title 75
###begin article-title 76
Naive T cell recruitment to nonlymphoid tissues: a role for endothelium-expressed CC chemokine ligand 21 in autoimmune disease and lymphoid neogenesis
###end article-title 76
###begin article-title 77
###xml 46 54 <span type="species:ncbi:9606">children</span>
Thymus and activation regulated chemokines in children with atopic dermatitis: Kyushu University Ishigaki Atopic Dermatitis Study (KIDS)
###end article-title 77
###begin p 78
###xml 31 39 <span type="species:ncbi:9606">patients</span>
Clinical chatacteristics of AD patients.
###end p 78
###begin p 79
###xml 56 64 <span type="species:ncbi:9606">patients</span>
Median serum concentration of analyzed chemokines in AD patients (Group 1 and Group 2) and Controls (Control 1 and 2).
###end p 79

